Search results
Here's Why Merck (MRK) is a Strong Momentum Stock
Zacks· 2 days agoFor new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both ...
Is Merck Stock Fully Valued At $130?
Forbes· 4 days agoMerck (NYSE: MRK) recently reported its Q1 results, with revenues and earnings exceeding our estimates. The growth was primarily driven by higher sales...
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $143.00
ETF DAILY NEWS· 6 days agoMerck & Co., Inc. (NYSE:MRK – Free Report) had its target price boosted by Truist Financial from $142.00 to $143.00 in a research report released on Friday ...
Michael Burgess trades in AbbVie, IBM, iShares ETF, and Merck stocks By Investing.com
Investing.com· 2 days agoMichael Burgess trades in AbbVie, IBM, iShares ETF, and Merck stocks
What’s going on with the ImmunityBio (IBRX) stock price?
Invezz· 6 days agoImmunityBio (NASDAQ: IBRX) stock price has gone parabolic as investors cheer the recent approval of...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 3 days agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats...
Cerevance receives milestone payment under Alzheimer's collaboration with Merck
Seeking Alpha· 3 days agoPrivately held Cerevance receives milestone payment from Merck for Alzheimer's research...
Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com
Investing.com· 4 days agoMerck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...
Merck KGaA's Dividend Analysis
Guru Focus· 6 days agoMerck KGaA (MKKGY, Financial) recently announced a dividend of $0.47 per share, payable on 2024-05-09, with the ex-dividend date set for 2024-04-29. As investors look forward ...
